Abacaviri sulfas, Lamivudinum, Zidovudinum

Medicinal product name Trizivir
Pharmaceutical form Film-coated tablet
Strength 300 mg/150 mg/300 mg 
Information from the MAH on shortages Not notified
Legal status Rx Prescription (Pr.)
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Risk minimisation measuresIzglītojošie materiāli pacientam Izglītojošie materiāli pacientam
ATC code J05AR04 Antivirals for systemic use

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Not available (according to the information provided by wholesalers) currently no information on availability from any wholesaler N60
(1 UD)
PVC/PCTFE/AL blister    EU/1/00/156/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website

Registration information

Marketing authorisation No. EU/1/00/156/002
Date of authorisation Dec 28, 2000
Marketing authorisation holder, country Viiv Healthcare B.V., Netherlands